期刊文献+

RTS,S/AS01疟疾疫苗大规模现场应用可能面临的挑战

Potential challenges for large-scale uses of RTS,S/AS01 vaccine in malaria-endemic areas
原文传递
导出
摘要 RTS,S/AS01疟疾疫苗获得WHO批准大规模应用是人类抗击寄生虫感染史上的一个里程碑,然而RTS,S/AS01疫苗并非完美。本文从免疫学角度探讨了RTS,S/AS01疟疾疫苗存在的不足以及下一代疟疾疫苗研发可能面临的挑战。 RTS,S/AS01 vaccine has recently been recommended by the WHO for large-scale uses in malaria-endemic areas,which is a milestone in the history of the fight against parasitic infections.Nevertheless,RTS,S/AS01 vaccine is not perfect.Hereby,the shortages of RTS,S/AS01 malaria vaccine were discussed,and the potential challenges during the research and development of next-generation malaria vaccines were analyzed.
作者 冯高谦 FENG Gao-qian(Burnet Institute,Melbourne 3004,Australia;Department of Medicine,The University of Melbourne,Melbourne 3052,Australia)
出处 《中国血吸虫病防治杂志》 CAS CSCD 北大核心 2021年第6期553-554,559,共3页 Chinese Journal of Schistosomiasis Control
关键词 疟疾 RTS S/AS01疫苗 保护性免疫 Malaria RTS,S/AS01 vaccine Protective immunity
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部